- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02800122
PAthwAy of Dyspneic patIent in Emergency (PArADIsE) (PArADIsE)
PAthwAy of Dyspneic patIent in Emergency
This is an observational retrospective single-center study (CHRU of Nancy) in patients cared for acute dyspnea by a medical team of the emergencies of the CHRU of Nancy.
The main purpose of the study is to evaluate the outcome of patients cared for acute dyspnea by a medical team of emergencies of CHRU of Nancy.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Tahar CHOUIHED, MD, PhD
- Phone Number: + 33 3 83 15 73 88
- Email: t.chouihed@chru-nancy.fr
Study Contact Backup
- Name: Nicolas GIRERD, MD, PhD
- Phone Number: +33383157322
- Email: n.girerd@chru-nancy.fr
Study Locations
-
-
-
Nancy, France, 54000
- Recruiting
- CHRU Nancy - Service des Urgences
-
Contact:
- Tahar CHOUIHED, MD
- Phone Number: +33 3 83 85 14 96
- Email: t.chouihed@chru-nancy.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Man or women ≥ 18 years
- Patients with acute dyspnea cared by a medical team of the emergencies of CHRU of Nancy.
Exclusion Criteria:
- Cardiorespiratory arrest before the care by a medical team of the emergencies of the CHRU of Nancy.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Patients with acute dyspnea
Patients with acute dyspnea treated by a medical team of emergencies of CHRU of Nancy. All patients admitted to the emergencies in the last 5 years matching the inclusion criteria will be evaluated. About 4,000 patients will be affected, including more than 800 patients with acute heart failure. (Figures based on export of ICD X codes (R06.0: Dyspnea) of patients cared in extra-hospital for acute dyspnea (diagnosis Dyspnea + Heart Failure) over the last 5 years). |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
All cause in-hospital mortality
Time Frame: in the last 5 years
|
in the last 5 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Demographic and clinical data of patients cared by a medical team of emergencies
Time Frame: in the last 5 years
|
in the last 5 years
|
Duration of total hospitalization (including emergency stay and conventional hospitalization)
Time Frame: in the last 5 years
|
in the last 5 years
|
The main diagnosis of the initial hospitalization
Time Frame: in the last 5 years
|
in the last 5 years
|
Rate of Brain Natriuretic Peptide (BNP)
Time Frame: in the last 5 years
|
in the last 5 years
|
Administration of non-invasive ventilation and / or diuretics and / or nitrates
Time Frame: in the last 5 years
|
in the last 5 years
|
Administration time of non-invasive ventilation and / or diuretics and / or nitrates
Time Frame: in the last 5 years
|
in the last 5 years
|
Service type admitting the patient after the emergency care (intensive care, cardiology, intensive care cardiology, other ...)
Time Frame: in the last 5 years
|
in the last 5 years
|
Admission time in a service after the emergency care
Time Frame: in the last 5 years
|
in the last 5 years
|
Mortality and re-hospitalization of included patients
Time Frame: in the last 5 years
|
in the last 5 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nicolas GIRERD, MD, Central Hospital, Nancy, France
- Principal Investigator: Tahar CHOUIHED, MD, PhD, Central Hospital, Nancy, France
Publications and helpful links
General Publications
- Chouihed T, Bassand A, Duarte K, Jaeger D, Roth Y, Giacomin G, Delaruelle A, Duchanois C, Bannay A, Kobayashi M, Rossignol P, Girerd N. Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort. Intern Emerg Med. 2022 Jun;17(4):1155-1163. doi: 10.1007/s11739-021-02879-6. Epub 2021 Nov 17.
- Chouihed T, Buessler A, Bassand A, Jaeger D, Virion JM, Nace L, Barbe F, Salignac S, Rossignol P, Zannad F, Girerd N. Hyponatraemia, hyperglycaemia and worsening renal function at first blood sample on emergency department admission as predictors of in-hospital death in patients with dyspnoea with suspected acute heart failure: retrospective observational analysis of the PARADISE cohort. BMJ Open. 2018 Mar 30;8(3):e019557. doi: 10.1136/bmjopen-2017-019557.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R2016-08
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Disease
-
Mesoblast, Inc.Quintiles, Inc.CompletedGrade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host DiseaseUnited States
-
Cynata Therapeutics LimitedRecruitingGraft Versus Host Disease, AcuteUnited States, Australia, Turkey
-
Hospital de Clinicas de Porto AlegreRecruitingCritical Illness | Acute Kidney Injury | Fluid Overload | Renal Insufficiency, Acute | Volume Overload | Kidney; Disease, AcuteBrazil
-
The First Affiliated Hospital of Soochow UniversityRecruiting
-
Sheba Medical CenterUnknownStem Cell Transplant Complications | Fecal Microbiota Transplantation | Graft Versus Host Disease, AcuteIsrael
-
EquilliumBiocon LimitedRecruitingGraft Versus Host Disease | GVHD | aGVHD | Acute-graft-versus-host Disease | Acute GVHDUnited States, Korea, Republic of, Israel, Spain, Germany, Belgium, Italy, Australia, France, Canada, Portugal
-
Jonsson Comprehensive Cancer CenterWithdrawnAcute Graft Versus Host Disease | Gastrointestinal Tract Acute Graft Versus Host Disease | Severe Gastrointestinal Tract Acute Graft Versus Host Disease | Steroid Resistant Gastrointestinal Tract Acute Graft Versus Host DiseaseUnited States
-
EquilliumBiocon LimitedRecruitingGVHD | GVHD, Acute | aGVHD | Acute-graft-versus-host DiseaseUnited States
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNanjing Legend Biotech Co.TerminatedAcute Myeloid Leukemia | Acute Leukemia | Acute Leukemia in Relapse | Relapsed or Refractory Acute LeukemiaChina
-
Actinium PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Leukemia, Myeloid, Acute | AML | Acute Myelogenous Leukemia | Bone Marrow Transplant | Myelogenous Leukemia, Acute | Myeloid Leukemia, Acute | Leukemia, Acute Myelogenous | Leukemia, Acute MyeloidUnited States, Canada